Baltic Beer Company to produce cannabis-flavored beer in Tallinn

The U.K. based company Baltic Beer Company Ltd, which sells Estonian beer of the Viru Beer brand in several countries all over the world, is about to start producing beer containing various ingredients, seeds, extracts and terpenes from hemp and cannabis plants in Tallinn in collaboration with partners from Canada and Australia, informs LETA/BNS.

Creso Pharma, Australian developer and producer of pharmaceutical-grade nutraceuticals and medical cannabis products, announced on Thursday that they have teamed up with the Canadian financial investorLGC CapitalandBaltic Beer Companyto seat up a company namedCLV Frontier Brands PtyLtd.

Under the agreement,Creso PharmaandLGC Capitalwill both invest 150,000 euros in the venture, whereasBaltic Beer Companywill make a contribution of the same size in the form of services - writes baltic-course.com.

"CLV intends to establish a pilot R&D brewing facility in Tallinn, Estonia which will be dedicated to working on innovative recipes and developing proprietary know-how and IP which will be registered by the joint venture. CLV will distribute and market products strictly in compliance with all local laws," the press release reads.

It says that CLV is currently developing an initial premium four-beer range containing unique cannabis terpene mixes as well as other innovative ingredients. These unique terpenes will carry the flavor and aroma of cannabis and will provide a sensual cannabis experience, but will not contain THC or CBD or any other cannabinoids.

Read more news of Tallinn on our site.

Baltic Beer Companyis a UK based company that created and markets the Estonian beer brand called Viru Premium Estonian Beer. Viru Beer is currently sold in numerous markets around the world including Australia, China, UK, Italy and Mexico.

baltic-course.com
cannabis-flavoredbeerinTallin
If you notice an error, highlight the text you want and press Ctrl + Enter to report it to the editor
No recommendations yet
Log in ,
to rate and recommend

Comments

Post your comment to communicate and discuss this article.

No results found.